Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study

Kimiaki Utsugisawa, Masayuki Masuda, Babak Boroojerdi, Fiona Grimson, James F. Howard

Open source

DOI
10.1016/j.jns.2025.123550
Published
2025-07
Container
Journal of the Neurological Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jns.2025.123550,
  title = {Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study},
  author = {Kimiaki Utsugisawa and Masayuki Masuda and Babak Boroojerdi and Fiona Grimson and James F. Howard},
  year = {2025},
  journal = {Journal of the Neurological Sciences},
  doi = {10.1016/j.jns.2025.123550},
  url = {https://doi.org/10.1016/j.jns.2025.123550}
}

RIS

TY  - JOUR
TI  - Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study
AU  - Kimiaki Utsugisawa
AU  - Masayuki Masuda
AU  - Babak Boroojerdi
AU  - Fiona Grimson
AU  - James F. Howard
PY  - 2025
JO  - Journal of the Neurological Sciences
DO  - 10.1016/j.jns.2025.123550
UR  - https://doi.org/10.1016/j.jns.2025.123550
ER  - 

APA

Utsugisawa, K., Masuda, M., Boroojerdi, B., Grimson, F., & Howard, J. F. (2025). Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2025.123550

Source records